View the accessible transcript of this podcast
Dr Emma Gray talks to Professor Allan Gaw about the clinical trial platform for Multiple Sclerosis studies, known as 'Octopus'.
She explains how the Multi-Arm, Multi-Stage platform trial design will help to speed up the development of novel or repurposed treatments for MS that can slow neurodegeneration and/or protect nerves from further damamge (neuroprotective). She also explains how the research team looked to the STAMPEDE prostate cancer trial for inspiration, and how cross-sector collaboration with the NIHR, the life sciences industry and chariites was crucial.
This podcast is part of our 'Persectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517
To find out more about how the NIHR supports complex and innovative design trials, visit: www.nihr.ac.uk/innovative-trials
